Microarray technology in the study of obesity and non-alcoholic fatty liver disease

Liver International

Volumn 25, Issue 6, 2005, Pages 1091-1096

  Baranova, Ancha ^a   Schlauch, Karen ^a   Gowder, Shobha ^a   Collantes, Rochelle ^a   Chandhoke, Vikas ^a   Younossi, Zobair M ^a  

^a INOVA FAIRFAX HOSPITAL   (United States)

Author keywords

Gene expression; Microarray; NAFLD; Obesity

Indexed keywords

ALPHA FETOPROTEIN; COMPLEMENTARY DNA; CYSTEINE RICH PROTEIN 61; MESSENGER RNA; NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR;

DNA MICROARRAY; DRUG TARGETING; FATTY LIVER; FUNCTIONAL GENOMICS; GENE EXPRESSION PROFILING; GENE TARGETING; HIGH THROUGHPUT SCREENING; HUMAN; INFORMATION PROCESSING; LIVER CELL CARCINOMA; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; MOLECULAR BIOLOGY; OBESITY; PROTEIN DATABASE; PROTEIN MICROARRAY; REVIEW;

FATTY LIVER; GENE EXPRESSION PROFILING; HUMANS; OBESITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 28944441246     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2005.01183.x     Document Type: Review

References (34)

1. Guttmacher A E, Collins F S. Genomic medicine - a primer. N Engl J Med 2002; 347: 1512-20.
2. The International SNP Map Working Group. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001; 409: 928-33.
3. Younossi Z M, Diehl A M, Ong J P. Non-alcoholic fatty liver disease: an agenda for clinical research. Hepatology 2002; 35: 746-52.
4. Wisse B E. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004; 15: 2792-800.
5. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-31.
6. Ong J P, Younossi Z M, Speer C, Olano A, Gramlich T, Boparai N. Chronic hepatitis C and superimposed nonalcoholic fatty liver disease. Liver 2001; 21: 266-71.
7. Younossi Z, Gramlich T, Matteoni C, Boparai N, McCullough A. Non-alcoholic fatty liver disease in patients with type II diabetes. Clin Gastroenterol Hepatol 2004; 2: 262-5.
8. Friis-Liby I, Aldenborg F, Jerlstad P, Rundstrom K, Bjornsson E. High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease. Scand J Gastroenterol 2004; 39: 864-9.
9. Barrett J C, Kawasaki E S. Microarrays: the use of oligonucleotides and cDNA for the analysis of gene expression. Drug Discov Today 2003; 8: 134-41.
10. Parmigiani G, Garrett ES, Irizarry R, Zeger SL., eds. The Analysis of Gene Expression Data: Methods and Software. New York: Springer, 2003.
11. Mootha V K, Lindgren C M, Eriksson K F, Subramanian A, Sihag S, Lehar J, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003; 34(3): 267-73.
12. Kerr M K, Martin M, Churchill G A. Analysis of variance for gene expression microarray data. J Comput Biol 2000; 7: 819-37.
13. Gomez-Ambrosi J, Catalan V, Diez-Caballero A, Martinez-Cruz L A, Gil M J, Garcia-Foncillas J, et al. Gene expression profile of omental adipose tissue in human obesity. FASEB J 2004; 18: 215-7.
14. Baranova A, Collantes R, Gowder S J, Elariny H, Schlauch K, Younoszai A, et al. Obesity-related differential gene expression in the visceral adipose tissue. Obes Surg 2005; 15: 758-65.
15. Clement K, Viguerie N, Poitou C, Carette C, Pelloux V, Curat CA, et al. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 2004; 18: 1657-69.
16. Sreekumar R, Rosado B, Rasmussen D, Charlton M. Hepatic gene expression in histologically progressive non-alcoholic steatohepatitis. Hepatology 2003; 38: 244-51.
17. Younossi Z M, Gorreta F, Ong J P, Schlauch K, Gorreta F, Del Giacco L, et al. Hepatic Gene Expression in patients with obesity-related non-alcoholic steatohepatitis. Liver Int 2005; 25: 1-12.
18. Linder K, Arner P, Flores-Morales A, Tollet-Egnell P, Norstedt G. Differentially expressed genes in visceral or subcutaneous adipose tissue of obese men and women. J Lipid Res 2004; 45: 148-54.
19. Kmiec Z. Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol 2001; 161: 1-151.
20. Fain J N, Madan A K, Hiler M L, Cheema P, Bahouth S W. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004; 145: 2273.
21. Soukas A, Socci N D, Saatkamp B D, Novelli S, Friedman J M. Distinct transcriptional profiles of adipogenesis in vivo and in vitro. J Biol Chem 2001; 276: 34167-74.
22. Ruan H, Zarnowski M J, Cushman S W, Lodish H F. Standard isolation of primary adipose cells from mouse epididymal fat pads induces inflammatory mediators and down-regulates adipocyte genes. J Biol Chem 2003; 278: 47585-9.
23. Vohl M C, Sladek R, Robitaille J, Gurd S, Marceau P, Richard D, et al. A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men. Obes Res 2004; 12: 1217-22.
24. Wong LY, Hafeman A, Boyd V L, Bodeau J, Lazaruk K D, Liew S N, et al. Assessing gene expression variation in normal human tissues using GeneTag, a novel, global, sensitive profiling method. J Biotechnol 2003; 101: 199-217.
25. Rinn J L, Rozowsky J S, Laurenzi I J, Petersen P H, Zou K, Zhong W, et al. Major molecular differences between mammalian sexes are involved in drug metabolism and renal function. Dev Cell 2004; 6: 791-800.
26. Dobbin K, Simon R. Sample size determination in micro-array experiments for class comparison and prognostic classification. Biostatistics 2005; 6: 27-38.
27. Permana P A, Del Parigi A, Tataranni P A. Microarray gene expression profiling in obesity and insulin resistance. Nutrition 2004; 20: 134-8.
28. Ribeiro P S, Cortez-Pinto H, Sola S, Castro R E, Ramalho R M, Baptista A, et al. Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients. Am J Gastroenterol 2004; 99: 1708-17.
29. Fromenty B, Robin M A, Igoudjil A, Mansouri A, Pessayre D. The ins and outs of mitochondrial dysfunction in NASH. Diabetes Metab 2004; 30: 121-38.
30. Crespo J, Cayon A, Fernandez-Gil P, Hernandez-Guerra M, Mayorga M, Dominguez-Diez A, et al. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 2001; 34: 1158-63.
31. Kim J W, Ye Q, Forgues M, Chen Y, Budhu A, Sime J, et al. Cancer-associated molecular signature in the tissue samples of patients with cirrhosis. Hepatology 2004; 39: 518-27.
32. Smith M W, Yue Z N, Korth M J, Do H A, Boix L, Fausto N, et al. Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers. Hepatology 2003; 38: 1458-67.
33. Patzwahl R, Meier V, Ramadori G, Mihm S. Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization. J Virol 2001; 75: 1332-8.
34. Bigger C B, Guerra B, Brasky K M, Hubbard G, Beard M R, Luxon B A, et al. Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. J Virol 2004; 78: 13779-92.